Demo Sign up Log In

Regeneron Pharmaceuticals (REGN)

Cost of Revenue

$2.35B

TTM · Period ending: Jun 30, 2026 · USD

REGN Cost of Revenue

Latest reported$2.35Bperiod endingJun 30, 2026

Latest reported$2.35Bperiod endingJun 30, 2026

REGN TTM Cost of Revenue ($0.00 → $2.35B)

TTM cost of revenue

High-resolution chart · PNG

REGN cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Regeneron Pharmaceuticals Cost of Revenue — Trailing twelve months (TTM) (USD)
Period ending	Cost of Revenue (USD)
Jun 30, 2001	15,323,000
Mar 31, 2001	14,703,000
Dec 31, 2000	15,566,000
Sep 30, 2000	6,928,000
Jun 30, 2000	5,416,000
Mar 31, 2000	5,351,000
Dec 31, 1999	3,600,000
Sep 30, 1999	5,100,000
Jun 30, 1999	5,400,000
Mar 31, 1999	5,400,000
Dec 31, 1998	5,000,000
Sep 30, 1998	4,300,000
Jun 30, 1998	3,800,000
Mar 31, 1998	3,100,000
Dec 31, 1997	2,700,000
Sep 30, 1997	1,800,000
Jun 30, 1997	1,000,000
Mar 31, 1997	500,000
Dec 31, 1996	0
Sep 30, 1996	0
Jun 30, 1996	0
Mar 31, 1996	0
Dec 31, 1995	0
Sep 30, 1995	0
Jun 30, 1995	0
Mar 31, 1995	0
Dec 31, 1994	0
Sep 30, 1994	0
Jun 30, 1994	10,600,000
Mar 31, 1994	10,600,000
Dec 31, 1993	10,600,000
Sep 30, 1993	10,600,000
Jun 30, 1993	0
Mar 31, 1993	0
Dec 31, 1992	0
Sep 30, 1992	5,000,000
Jun 30, 1992	7,400,000
Mar 31, 1992	10,300,000
Dec 31, 1991	10,300,000
Sep 30, 1991	5,300,000
Jun 30, 1991	2,900,000
Mar 31, 1991	0
Dec 31, 1990	0

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.